Drug metabolism is required to convert lipophilic compounds into more hydrophilic compounds so they can be excreted
If lipid soluble non-polar compounds (drugs) are not metabolised, they will remain in the blood and tissues and maintain their pharmacological effects for much longer
Pharmacokinetics refers to the movement of drugs throughout the body and involves the drug's:
Absorption
Metabolism
Distribution
Elimination
Orally administered drugs dissolve in the GI tract and are absorbed through the gut, where they then enter the liver and then the bloodstream, where they are circulated
Successful absorption of a drug is influenced by its ability to cross membranes
Chemical stability of a drug is influenced by, e.g. its stability in the stomach - resistance to extremes of pH and protease degradation
Metabolic stability requires the drug to, e.g. have no interaction with other metabolites
Phase I transformations introduce or unmask a functional group of a drug, e.g. by oxygenation or hydrolysis
Examples of functional groups introduced to drugs during Phase I transformation:
Hydroxyl (OH)
Thiol (SH)
Amine (NH2)
Carboxylic acid (COOH)
Phase II transformations generate highly polar derivates that can be excreted, by introducing:
Glucuronide
Sulfate
Acetate
Phase I metabolism consists of either:
Oxidation - addition of oxygen or removal of hydrogen.
Reduction - removal of oxygen or addition of hydrogen.
Reduction is less common than oxidation
Cytochrome P450 system in liver is always responsible for phase I oxidation but not always for phase II reduction; this can take place via reductases in different sites in the body
Oxidation of metabolites results in increased polarity, causing increased water solubility and therefore causing the metabolite to be excreted in urine
Phase I oxidation reactions include:
Aliphatic or aromatic hydroxylation
N-, or S-oxidation
N-, O-, S-dealkylation
Phase I reduction reactions include:
Nitro reduction to hydroxylamine/ amine
Carbonyl reduction to alcohol
Hydrolysis of metabolites produces more polar metabolites due to the addition of water
Esterase and amidase enzymes can hydrolyse drugs
Summary of metabolite oxidation enzymes:
Cytochrome P450 monooxygenase system
Alcohol dehydrogenase
Aldehyde dehydrogenase
Flavin-containing monooxygenase system
Monoamine oxidase
Summary of metabolite reduction enzymes:
NADPH-cytochrome P450 reductase
Reduced (ferrous) cytochrome P450
Summary of metabolite hydrolysis enzymes:
Esterases and amidases
Epoxide hydrolase
Phase I metabolism takes place via a microsomal mixed-function oxidase system that is cytochrome P450, oxygen and NADPH dependent
Oxidation takes place in the binding site of cytochrome P450; NADPH transfers electrons to P450
The mixed-function P450 oxidase is found in microsomes within the endoplasmic reticulum of many cell types (liver, kidney, lung and intestine)
Cytochrome P450 is anchored to the endoplasmic reticulum by an amphipathic helix
NADPH-cytochrome P450 reductase is a flavoenzyme containing FAD and FMN and is responsible for transferring electrons to P450
A haem group is co-ordinated in the binding site of P450. Fe3+ ions are reduced to Fe2+ to oxidise the substrate and vice versa
The cytochrome P450 binding site is described as promiscuous because it can accommodate a wide range of functional groups and isoforms
The promiscuity of the P450 binding site comes from the large binding site - successful binding is reliant on conducive orientation with S-warfarin and the haem group, which is accommodated by Cys435
When the products of Phase I metabolism are not sufficiently hydrophilic or inactive to be eliminated, they must undergo Phase II metabolism as well.
Phase I reactions provide a functional group to undergo Phase II reactions; Phase II reactions modify functional groups by a conjugation reaction.
Phase II reactions require coenzymes (i.e. enzymes to operate alongside P450) due to the handling of large polar compounds
Conjugation reactions in Phase II are catalysed by transferases
Reactions that can happen in Phase II metabolism:
Glucuronidation
Sulfation
Acetylation
Amino acid conjugation
Glutathione conjugation
Fatty acid conjugation
Condensation reactions
Glucuronidation is the most important Phase II pathway for drugs.
Products of glucuronidation are often excreted in the bile
General pathway of glucuronidation:
Addition of UDP via phosphorylase (UTP -> PPi)
Oxidation via UDP dehydrogenase (2 NAD+ -> 2 NADH)
N-glucuronidation:
Occurs with aromatic amines
Occurs with amides and sulfonamides
O-glucuronidation:
Occurs by ester linkages with carboxylic acids
Occurs by ether linkages with phenols and alcohols
Sulfation is the major Phase II pathway for phenols
Sulfation takes place at low substrate concentrations, whereas glucuronidation takes place at high substrate concentrations